GEM3 collaborative2023-03-202023-03-202023-02-25GEM3 collaborative 2023, 'Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3) : a multicentre, randomised, double-blind, placebo-controlled trial', Lancet (London, England), vol. 401, no. 01377, pp. 655-663. https://doi.org/10.1016/S0140-6736(22)02478-30140-6736https://hdl.handle.net/2164/20316AWH has received funding from NIHR HTA and UK Research and Innovation. WCD is immediate past chair of the Society for Reproduction and Fertility. BWM is supported by an the National Health and Medical Research Council Investigator grant (GNT1176437). AC is immediate past member of the NIHR Efficacy and Mechanism Evaluation Programme Funding Committee. JPD is a member of the NIHR Clinical Trials Unit Standing Advisory Committee.9939798engSDG 3 - Good Health and Well-beingR MedicineNational Institute for Health Research (NIHR)Medical Research Council (MRC)GNT1176437UK Research and Innovation (UKRI)RJournal article10.1016/S0140-6736(22)02478-340101377